MMRF CoMMpass Study: If you are newly diagnosed with multiple myeloma you can participate in this groundbreaking, landmark study
designed to uncover the molecular segments and
variations in multiple myeloma. Learn more.
A Phase 3 clinical trial, evaluating the combination of carfilzomib and low-dose
dexamethasone versus combination of bortezomib and low-dose dexamethasone.